Results 241 to 250 of about 28,159,239 (344)

Conformal predictive intervals in survival analysis: a resampling approach. [PDF]

Biometrics
Qin J, Piao J, Ning J, Shen Y.
europepmc   +1 more source

gwasurvivr: an R package for genome wide survival analysis

bioRxiv, 2018
Abbas A. Rizvi, Ezgi Karaesmen, Martin T. Morgan, Leah M Preus, Junke Wang, Michael G. Sovic, T. Hahn, Lara E Sucheston-Campbell   +7 more
semanticscholar   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Survival analysis for sepsis patients: A machine learning approach to feature selection and predictive modeling. [PDF]

Sci Rep
Cai K, Yang X, Wang Z, Fu W, Liu H, Mahmoudi F.   +5 more
europepmc   +1 more source

901-33 Should Age be a Consideration in Mode Selection in Permanent Pacing? A Survival Analysis

, 1995
Win K. Shen, S Neubauer, Raúl E. Espinosa, Stephen C. Hammill, Kent R. Bailey, David L. Hayes   +5 more
openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

Bladder angiosarcoma: a systematic literature review and survival analysis. [PDF]

Proc (Bayl Univ Med Cent)
Silwal A, B R S, Rehman S, Daing A, Gopagoni R, Alyas Akram M, Saeed A, Sadiq KO, Farrukh AM, Harikrishna A.   +9 more
europepmc   +1 more source

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma

, 1999
Kevin G. Billingsley, Jonathan J. Lewis, Denis H. Y. Leung, Ephraim S. Casper, James M. Woodruff, Murray F. Brennan   +5 more
openalex   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

Machine learning for grading prediction and survival analysis in high grade glioma. [PDF]

Sci Rep
Li X, Huang X, Shen Y, Yu S, Zheng L, Cai Y, Yang Y, Zhang R, Zhu L, Wang E.   +9 more
europepmc   +1 more source